RxPG News Feed for RxPG News

Medical Research Health Special Topics World
 Asian Health
 Food & Nutrition
 Men's Health
 Mental Health
 Occupational Health
 Public Health
 Sleep Hygiene
 Women's Health
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 World Healthcare
   Latest Research
 Alternative Medicine
 Clinical Trials
 Infectious Diseases
   Ankylosing Spondylitis
   Rheumatiod Arthritis
 Sports Medicine
   Medical News
 Awards & Prizes
   Special Topics
 Odd Medical News

Last Updated: Oct 11, 2012 - 10:22:56 PM
Arthritis Channel

subscribe to Arthritis newsletter
Latest Research : Rheumatology : Arthritis

   EMAIL   |   PRINT
New hope for tissue regeneration and joint repair

Mar 29, 2006 - 1:13:00 PM , Reviewed by: Priya Saxena
Study indicates therapeutic promise of adult human multipotent stem cells derived from the thick membrane covering the surface of bones

[RxPG] Inflammation, cartilage and bone erosions, joint destruction--that's the typical progression of arthritis and most rheumatic diseases. While inflammation may be controlled, and perhaps even eliminated, with early aggressive treatment, few therapeutic approaches offer hope for repairing tissue once the damage has been done. One promising strategy is the use of mesenchymal stem cells (MSCs). MSCs are capable of extensive self-renewal and adaptable to forming all kinds of connective tissues. While detected in several adult human tissues, MSCs have traditionally been obtained from bone marrow, an invasive, painful, and costly process.

Researchers in the United Kingdom and Belgium set out to investigate the characteristics of cells in the periosteum, the dense membrane at the boundary between the bone and the surrounding soft tissues. Their study, featured in the April 2006 issue of Arthritis & Rheumatism (http://www.interscience.wiley.com/journal/arthritis), is the first to identify periosteal cells as MSCs, with multipotent properties at the single cell level and the potential to regenerate cartilage, muscle, and bone in patients with inflammatory and degenerative rheumatic diseases.

Samples of periosteal cells were obtained from the tibia of 12 human donors, ranging in age from 24 to 83 years. Following enzymatic release and culture expansion, cell populations were tested for telltale markers of MSCs, as well as for their growth and differentiation potential. To assess their multipotency beyond the laboratory, the periosteal cells were then injected into one of three animal models: mice, with the goal of muscle regeneration; goats, with the goal of developing cartilage; and mice, with the goal of bone formation.

Regardless of donor age, periosteal cells expanded extensively, steadily maintaining growth curves over at least 30 population doublings. They also displayed the hallmarks of MSCs, including long telomeres, the sections of DNA at the end of a chromosome. What's more, the results of the animal experiments proved that expanded periosteal MSCs can contribute to muscle regeneration and form cartilage when implanted into a joint surface defect. The bone tissue retrieved from the last group of mice was partly human, which indicates the potential of these cells to build bone as well.

"Like MSCs derived from bone marrow, periosteal MSCs rapidly adhere to plastic and can be expanded for several passages, preserving their multipotency," notes study leader Dr. Cosimo De Bari, an MRC clinician scientist and consultant rheumatologist at King's College London, UK. "A small periosteal biopsy represents a relatively easily accessible source of MSCs."

This groundbreaking study calls attention to the need for more research into MSCs--in the periosteum and other tissues--and their practical therapeutic benefits for late-stage arthritis sufferers.

Publication: Article: "Mesenchymal Multipotency of Adult Human Periosteal Cells Demonstrated by Single-Cell Lineage Analysis," Cosimo De Bari, Francesco Dell'Accio, Johan Vanlauwe, Jeroen Eyckmans, Ilyas M. Khan, Charles W. Archer, Elena A. Jones, Dennis McGonagle, Thimios A. Mitsiadis, Costantino Pitzalis, and Frank P. Luyten, Arthritis & Rheumatism, April 2006, 54:4, pp. 1209-1221.
On the web: www.interscience.wiley.com/journal/arthritis 

Advertise in this space for $10 per month. Contact us today.

Related Arthritis News
DNA-covered submicroscopic bead used to deliver genes to treat rheumatoid arthritis
Rilonacept significantly reduced acute gout flares during uric acid-lowering therapy
Advances in genetics related to ankylosing spondylitis
Is Devil's Claw the key to treating arthritis?
High birth weight - risk for rheumatoid arthritis
Matrilin-3 gene discovered to prevent onset of osteoarthritis
Rituximab halts damage to joints
Tocilizumab effective in systemic juvenile idiopathic arthritis (sJIA)
Unfavourable blood fat levels predict rheumatoid arthritis up to 10 years later
Role of inflammatory leukocytes in extending tissue damage

Subscribe to Arthritis Newsletter

Enter your email address:

For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

Contact us

RxPG Online



    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)